155 related articles for article (PubMed ID: 19552638)
41. A Randomized Controlled Trial of Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis.
Danek BA; Karatasakis A; Abdullah K; Iwnetu R; Kalsaria P; Shunk K; Zimmet J; Vidovich M; Bavry AA; Rangan BV; Roesle M; Griza D; Stanley K; Banerjee S; Khalili H; Brilakis ES; Abdullah SM
J Invasive Cardiol; 2020 Dec; 32(12):E305-E312. PubMed ID: 32961528
[TBL] [Abstract][Full Text] [Related]
42. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
Warkentin TE; Arnold DM; Kelton JG; Sheppard JI; Smith JW; Nazy I
Chest; 2018 Jun; 153(6):1396-1404. PubMed ID: 29325985
[TBL] [Abstract][Full Text] [Related]
43. The relationship between dual antiplatelet treatment (DAPT) score and saphenous venous grafts patency after coronary artery bypass grafting surgery.
Bayam E; Öztürkeri B; Yıldırım E; Kalçık M; Küp A; Çakmak EÖ; Günay N; Güner A; Kalkan S; Karaduman A; Kahyaoğlu M; Zehir R
Acta Cardiol; 2021 Sep; 76(7):785-791. PubMed ID: 33880976
[TBL] [Abstract][Full Text] [Related]
44. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes.
Greinacher A; Juhl D; Strobel U; Wessel A; Lubenow N; Selleng K; Eichler P; Warkentin TE
J Thromb Haemost; 2007 Aug; 5(8):1666-73. PubMed ID: 17488345
[TBL] [Abstract][Full Text] [Related]
45. Ticagrelor versus aspirin and vein graft patency after coronary bypass: A randomized trial.
Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
J Card Surg; 2022 Mar; 37(3):563-570. PubMed ID: 34961950
[TBL] [Abstract][Full Text] [Related]
46. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia.
Ziporen L; Li ZQ; Park KS; Sabnekar P; Liu WY; Arepally G; Shoenfeld Y; Kieber-Emmons T; Cines DB; Poncz M
Blood; 1998 Nov; 92(9):3250-9. PubMed ID: 9787161
[TBL] [Abstract][Full Text] [Related]
47. Prospective observational evaluation of the particle immunofiltration anti-platelet factor 4 rapid assay in MICU patients with thrombocytopenia.
Andrews DM; Cubillos GF; Paulino SK; Seckinger DL; Kett DH
Crit Care; 2013 Jul; 17(4):R143. PubMed ID: 23876263
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
[TBL] [Abstract][Full Text] [Related]
49. IgG-class anti-PF4/heparin antibodies and symptomatic DVT in orthopedic surgery patients receiving different anti-thromboembolic prophylaxis therapeutics.
Motokawa S; Torigoshi T; Maeda Y; Maeda K; Jiuchi Y; Yamaguchi T; Someya S; Shindo H; Migita K
BMC Musculoskelet Disord; 2011 Jan; 12():22. PubMed ID: 21261941
[TBL] [Abstract][Full Text] [Related]
50. Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies.
Ahmad S; Haas S; Hoppensteadt DA; Lietz H; Reid U; Bender N; Messmore HL; Misselwitz F; Bacher P; Gaikwad BS; Jeske WP; Walenga JM; Fareed J
Thromb Res; 2002 Oct; 108(1):49-55. PubMed ID: 12586132
[TBL] [Abstract][Full Text] [Related]
51. Percutaneous Coronary Intervention of Saphenous Vein Graft.
Redfors B; Généreux P; Witzenbichler B; McAndrew T; Diamond J; Huang X; Maehara A; Weisz G; Mehran R; Kirtane AJ; Stone GW
Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495896
[TBL] [Abstract][Full Text] [Related]
52. Comparison of clinical outcomes in patients presenting with an acute coronary syndrome due to stent thrombosis or saphenous vein graft occlusion and undergoing percutaneous coronary intervention.
Ota H; Mahmoudi M; Lhermusier T; Magalhaes MA; Torguson R; Satler LF; Suddath WO; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2015 Dec; 16(8):441-6. PubMed ID: 26704310
[TBL] [Abstract][Full Text] [Related]
53. Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis.
Padmanabhan A; Jones CG; Bougie DW; Curtis BR; McFarland JG; Wang D; Aster RH
Blood; 2015 Jan; 125(1):155-61. PubMed ID: 25342714
[TBL] [Abstract][Full Text] [Related]
54. Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery.
Halabi AR; Alexander JH; Shaw LK; Lorenz TJ; Liao L; Kong DF; Milano CA; Harrington RA; Smith PK
Am J Cardiol; 2005 Nov; 96(9):1254-9. PubMed ID: 16253593
[TBL] [Abstract][Full Text] [Related]
55. Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodies.
Dyke CM; Aldea G; Koster A; Smedira N; Avery E; Aronson S; Spiess BD; Lincoff AM
Ann Thorac Surg; 2007 Sep; 84(3):836-9. PubMed ID: 17720385
[TBL] [Abstract][Full Text] [Related]
56. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia.
Amiral J; Wolf M; Fischer A; Boyer-Neumann C; Vissac A; Meyer D
Br J Haematol; 1996 Mar; 92(4):954-9. PubMed ID: 8616093
[TBL] [Abstract][Full Text] [Related]
57. Relationship between elevated platelet volume and saphenous vein graft disease.
Tavil Y; Sen N; Yazici HU; Hizal F; Açikgöz SK; Turfan M; Cengel A
Clin Invest Med; 2010 Jun; 33(3):E161-7. PubMed ID: 20519094
[TBL] [Abstract][Full Text] [Related]
58. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
Fieland D; Taylor M
Ann Pharmacother; 2012 Jan; 46(1):e3. PubMed ID: 22202498
[TBL] [Abstract][Full Text] [Related]
59. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.
Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE
J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586
[TBL] [Abstract][Full Text] [Related]
60. Incidence of antibodies to protamine sulfate/heparin complexes incardiac surgery patients and impact on platelet activation and clinical outcome.
Pouplard C; Leroux D; Rollin J; Amiral J; May MA; Gruel Y
Thromb Haemost; 2013 Jun; 109(6):1141-7. PubMed ID: 23636177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
